| __timestamp | Agios Pharmaceuticals, Inc. | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 5842000000 |
| Thursday, January 1, 2015 | 141827000 | 4646000000 |
| Friday, January 1, 2016 | 220163000 | 4126000000 |
| Sunday, January 1, 2017 | 292681000 | 4318000000 |
| Monday, January 1, 2018 | 1397000 | 4936000000 |
| Tuesday, January 1, 2019 | 1317000 | 4921000000 |
| Wednesday, January 1, 2020 | 2805000 | 5299000000 |
| Friday, January 1, 2021 | 18777000 | 12437000000 |
| Saturday, January 1, 2022 | 1704000 | 12391000000 |
| Sunday, January 1, 2023 | 9504000 | 8040000000 |
| Monday, January 1, 2024 | 4165000 | 10207000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost trends is crucial for investors and stakeholders. AstraZeneca PLC and Agios Pharmaceuticals, Inc. present a fascinating contrast in their cost of revenue from 2014 to 2023. AstraZeneca, a global leader, consistently reported costs in the billions, peaking at approximately $12.4 billion in 2021. This represents a staggering 113% increase from its 2016 low. Meanwhile, Agios Pharmaceuticals, a smaller player, saw its costs fluctuate significantly, with a notable peak in 2017, followed by a sharp decline in subsequent years. By 2023, Agios's costs were a mere fraction of AstraZeneca's, highlighting the scale difference between the two companies. This data underscores the diverse strategies and market positions within the pharmaceutical sector, offering insights into how companies manage their operational expenses over time.
Cost Insights: Breaking Down AstraZeneca PLC and Novartis AG's Expenses
Cost of Revenue Comparison: AstraZeneca PLC vs Pfizer Inc.
Analyzing Cost of Revenue: AstraZeneca PLC and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
AstraZeneca PLC vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Zoetis Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Agios Pharmaceuticals, Inc. vs Galapagos NV